http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7888763
Outgoing Links
Predicate | Object |
---|---|
contentType | Comparative Study|Editorial |
endingPage | 3 |
issn | 1179-2027 1170-7690 |
issueIdentifier | Supplement 4 |
pageRange | 1-3 |
publicationName | PharmacoEconomics |
startingPage | 1 |
bibliographicCitation | Cannon CP. Cost-effectiveness of clopidogrel. Pharmacoeconomics. 2004;22 Suppl 4():1–3. doi: 10.2165/00019053-200422004-00002. PMID: 15876006. |
creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4963111378238fe435c24b2873d57c6c |
date | 200412 |
identifier | https://pubmed.ncbi.nlm.nih.gov/15876006 https://doi.org/10.2165/00019053-200422004-00002 |
isPartOf | https://portal.issn.org/resource/ISSN/1179-2027 https://portal.issn.org/resource/ISSN/1170-7690 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21262 |
language | English |
source | https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title | Cost-effectiveness of clopidogrel |
discusses | http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0021526 |
Incoming Links
Total number of triples: 28.